Journals
Publish with us
Publishing partnerships
About us
Blog
Journal of Oncology
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Journal of Oncology
/
2022
/
Article
/
Tab 4
/
Research Article
Computational Drug Repurposing Approach to Identify Novel Inhibitors of ILK Protein for Treatment of Esophageal Squamous Cell Carcinoma
Table 4
ILK affinity in selected compounds and ILK-IN-3 (control) measured by SPR experiments.
Receptor
Ligand
KD (M)
R
max
(RU)
ILK protein
ILK-IN-3 (control)
2.64
E
− 06
4.724
Nilotinib
6.41
E
− 06
12.52
Teniposide
1.79
E
− 06
2.386